Received May 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | 2 | Y016291 | OT / RA |
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | 1 | — | — |
About a week after I had the PNEUOMVAX 23 injection, I developed a red, painful lump on my right leg on the inner side just above the knee/they did an ultrasound which just showed inflammation.; and about 24 hours after I was administered the vaccine on 3/26/2025, my right arm became red, swollen, and painful from where the injection was given all the way down my right arm to my antecubital and even across the right side of my chest.; and about 24 hours after I was administered the vaccine on 3/26/2025, my right arm became red, swollen, and painful from where the injection was given all the way down my right arm to my antecubital and even across the right side of my chest.; and about 24 hours after I was administered the vaccine on 3/26/2025, my right arm became red, swollen, and painful from where the injection was given all the way down my right arm to my antecubital and even across the right side of my chest.; I was administered the PNEUMOVAX 23 vaccine on 3/26/2025; and about 24 hours after I was administered the vaccine on 3/26/2025, my right arm became red, swollen, and painful from where the injection was given all the way down my right arm to my antecubital and even across the right side of my chest.; This spontaneous report was received from a nurse regarding herself, a 76-year-old female patient. Her medical history was not reported. Historical drugs included Prevnar 20 (Pneumococcal vaccine conj 20v (CRM197)), bacitracin, and Gentamycin (Gentamicin). The patient's concurrent conditions included hypothyroidism. Allergies included bacitracin, and Gentamycin (Gentamicin), nickel, and gold. Concomitant medications included Cyanocobalamin, Levothyroxine, Vitamin D2, and Valaciclovir. On 23-Mar-2023, the patient was vaccinated with the first dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23), Solution for injection, as prophylaxis (dose, route of administration, lot #, and expiration date were not reported), after which, there was no reaction (she also received Prevnar 20 (Pneumococcal vaccine conj 20v (CRM197)) on 13-Mar-2024, also with no reaction). On 26-Mar-2025, the patient was vaccinated with the second dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) (lot #Y016291, that was a valid lot number for Pneumococcal Vaccine, Polyvalent (23-valent); expiration date: 06-Dec-2026), at a dose of 0.5 mL once, administered by intramuscular route in the right arm as pneumococcal prevention (Inappropriate schedule of vaccine administered). On the same day (conflicting information, also reported as about 24 hours after she was administered the vaccine), her right arm became red, swollen, and painful from where the injection was given all the way down to her right antecubital and even across the right side of her chest (Vaccination site erythema) (Vaccination site swelling) (Vaccination site pain) (Chest pain). On that day (also reported as when her symptoms began), she went to her doctor's office and they gave her an antibiotic injection of Rocephin (ceftriaxone) and a steroid injection (unspecified). She prescribed her prednisone 25 mg daily for 5 days, doxycycline 100 mg twice a day for 10 days, and a topical cream (unspecified) as needed. On an unspecified date in April 2025 (reported as about a week later, after she had the suspect vaccine's injection), she developed a red, painful lump on her right leg on the inner side just above the knee, so she went to see her vascular doctor on 03-Apr-2025 and they did an ultrasound which just showed inflammation (Inflammation localised). As a result of these events, her doctor told her that she would no longer be getting Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) injections. Patient stated that all her issues had all resolved now (on an unspecified date in April 2025, for inflammation localized and on an unspecified date in 2025, for the remaining events). The causal relationship between all the events and the suspect vaccine was not provided. Lot # is being requested and will be submitted if received.
Allergy to antibiotic; Allergy to gold; Hypothyroidism; Nickel allergy
CYANOCOBALAMIN; LEVOTHYROXINE; VITAMIN D2; VALACICLOVIR
Test Date: 20250403; Test Name: ultrasound; Result Unstructured Data: inflammation.